Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Liabilities and Shareholders Equity (2017 - 2025)

Historic Liabilities and Shareholders Equity for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $907.3 million.

  • Inspire Medical Systems' Liabilities and Shareholders Equity rose 1223.85% to $907.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year increase of 759.33%. This contributed to the annual value of $907.3 million for FY2025, which is 1223.85% up from last year.
  • As of Q4 2025, Inspire Medical Systems' Liabilities and Shareholders Equity stood at $907.3 million, which was up 1223.85% from $807.7 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Liabilities and Shareholders Equity registered a high of $907.3 million during Q4 2025, and its lowest value of $272.2 million during Q2 2021.
  • Over the past 5 years, Inspire Medical Systems' median Liabilities and Shareholders Equity value was $628.9 million (recorded in 2023), while the average stood at $578.3 million.
  • In the last 5 years, Inspire Medical Systems' Liabilities and Shareholders Equity soared by 33.17% in 2021 and then surged by 11172.66% in 2023.
  • Inspire Medical Systems' Liabilities and Shareholders Equity (Quarter) stood at $295.1 million in 2021, then skyrocketed by 91.43% to $564.9 million in 2022, then grew by 19.82% to $676.8 million in 2023, then rose by 19.44% to $808.4 million in 2024, then grew by 12.24% to $907.3 million in 2025.
  • Its Liabilities and Shareholders Equity was $907.3 million in Q4 2025, compared to $807.7 million in Q3 2025 and $802.2 million in Q2 2025.